Indoco Remedies Limited Hydroxychloroquine Export Data — India (DGFT 2022–2026)

Name: Indoco Remedies Limited Hydroxychloroquine Export Records India — #12 Exporter, 5 Shipments, $90.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Hydroxychloroquine

India Pharmaceutical Trade Intelligence

$141.5M163 Suppliers86 CountriesHS 30049099

ExportsIndia → UNITED STATES89.2%India → UNITED KINGDOM1.9%

ImportsUNITED STATES → India$9.0K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Indoco Remedies Limited — Hydroxychloroquine Exporter #12 | $90.6K Trade Value | TransData Nexus | TransData Nexus

Indoco Remedies Limited — Hydroxychloroquine Exporter Profile

Indian Pharmaceutical Exporter · #12 for Hydroxychloroquine · $90.6K export value · DGFT Verified

Indoco Remedies Limited is the #12 Indian exporter of Hydroxychloroquine with $90.6K in export value and 5 verified shipments. Indoco Remedies Limited holds a 0.1% market share in Hydroxychloroquine exports across 1 countries. The company exports 13 pharmaceutical products worth $73.5M across 9 therapeutic categories.

Indoco Remedies Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Indoco Remedies Limited Hydroxychloroquine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Hydroxychloroquine?

Country	Value	Shipments	Share
UNITED STATES	$14.6M	292	58.2%
UNITED KINGDOM	$2.6M	61	10.5%
THAILAND	$1.7M	34	6.8%
GERMANY	$1.5M	30

Who Are the Top Buyers of Hydroxychloroquine from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$10.0M	200
IPCA LABORATORIES UK LIMITED	UNITED KINGDOM	$2.6M	55
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$1.6M	33
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$750.0K	15
HAPHARCO J.S.C. BRANCH	VIETNAM	$450.0K	9
RANBAXY (THAILAND) CO., LTD.	THAILAND	$400.0K	8
EVERSANA LIFE SCIENCE SERVICES,	UNITED STATES	$350.0K	7
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$350.0K	7
SARL CPCM	ALGERIA	$200.0K	4
AMNEAL EU LIMITED	UNITED STATES	$100.0K	2

India's Hydroxychloroquine is purchased by 271 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by IPCA LABORATORIES UK LIMITED and NORTHSTAR DISTRIBUTION CENTER 8912.

How Does Indoco Remedies Limited Compare to Nearest Hydroxychloroquine Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	AMNEAL PHARMACEUTICALS PRIVATE LIMITED	$150.0K	3	2	$50.0K
11	WALLACE PHARMACEUTICALS PRIVATE LIMITED	$138.5K	6	3	$23.1K
12	INDOCO REMEDIES LIMITED ★	$90.6K	5	1	$18.1K

Indoco Remedies Limited ranks #12 among 163 Indian Hydroxychloroquine exporters. Average shipment value of $18.1K compared to the market average of $159.2K. The closest competitors by value are AMNEAL PHARMACEUTICALS PRIVATE LIMITED and WALLACE PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Hydroxychloroquine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	935	25.2%
SAHAR AIR	756	20.3%
DELHI AIR CARGO ACC (INDEL4)	610	16.4%
DELHI AIR	305	8.2%
Bombay Air	285	7.7%
MUNDRA SEA	137	3.7%
Delhi Air	116	3.1%
NHAVA SHEVA SEA (INNSA1)	76	2.0%

Geopolitical & Trade Policy Impact on Indoco Remedies Limited's Hydroxychloroquine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Indoco Remedies. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These maritime challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching up to 39% on imports from countries including India, poses a significant threat. These tariffs could affect approximately 55% of India's exports to the US, compelling companies like Indoco to reassess pricing strategies and explore new markets to mitigate potential revenue losses. (apnews.com)

In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, demand enhanced compliance measures from exporters. For Indoco, this necessitates investments in serialization and traceability technologies to ensure continued access to the EU market.

Indoco Remedies Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Indoco Remedies has faced challenges in this arena; for instance, the company's Goa sterile facility was placed under Official Action Indicated status by the USFDA, indicating significant compliance issues. Such regulatory setbacks can impede market access and necessitate substantial remediation efforts. (alphastreet.com)

The broader Indian pharmaceutical industry has also encountered increased scrutiny, with the USFDA conducting over 200 inspections in 2023 and planning to escalate this number in 2024. This heightened oversight underscores the critical importance of stringent quality control and compliance measures for companies like Indoco to maintain and expand their export markets. (fact.net.in)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Hydroxychloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Indoco Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 86+ countries, 271+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Hydroxychloroquine

Hydroxychloroquine

Indoco Remedies Limited — Hydroxychloroquine Exporter Profile

Indoco Remedies Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Where Does India Export Hydroxychloroquine?

Who Are the Top Buyers of Hydroxychloroquine from India?

What Is India's Total Hydroxychloroquine Export Value and How Much Does Indoco Remedies Limited Contribute?

What Is the Average Shipment Value for Indoco Remedies Limited's Hydroxychloroquine Exports?

How Does Indoco Remedies Limited Compare to Other Indian Hydroxychloroquine Exporters?

Regulatory Requirements: Exporting Hydroxychloroquine to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Indoco Remedies Limited Compare to Nearest Hydroxychloroquine Exporters?

Which Indian Ports Ship Hydroxychloroquine Exports?

What Other Antimalarial & Antiparasitic Products Does Indoco Remedies Limited Export?

Geopolitical & Trade Policy Impact on Indoco Remedies Limited's Hydroxychloroquine Exports

Indoco Remedies Limited — Regulatory Compliance & Quality Standards

About Indoco Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Hydroxychloroquine Export Data from Indoco Remedies Limited

Hydroxychloroquine Stats

Company Overview

Top Products by Indoco Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source